
Sanofi and IGM Biosciences Inc. in $6.15bn deal
Under the agreement, IGM Biosciences Inc. (Mountain View) will discover IgM antibody agonists against three oncology targets and...

Meletios Therapeutics licences antiviral patent
Meletios has signed an exclusive license agreement with Institut Pasteur to commercialise Defective Viral Genomes (DVG). DVGs are truncated or...

Vigeneron updates gene therapy collab with Daiichi Sankyo
Under the new agreement, Planegg-based AAV specialist ViGeneron GmbH will provide its novel engineered recombinant adeno-associated virus vectors...

AXA launches €440 m private equity healthcare strategy
The Strategy focuses specifically on companies in four core areas: medical devices, biopharmaceuticals, vaccines, and diagnostics. The...

Enzymaster raises $45m in Series C round
The Series C financing round was led by Yuanbio Venture Capital with While Bayland Capital, Puhua Capital, C&D Emerging Capital, Hansoh...

TargED Biopharmaceuticals BV raises €39m in Series A financing
Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures participated in the financing. Seed investors FIRST...

Sanofi bags €300m from US investor Blackstone
French Sanofi has secured €300m from US equity financing specialist Blackstone Life Sciences to accelerate pivotal studies of its subcutanous...